Showing results (1391-1400 of 1,437) with videos related to

Sort By:
Pageof 144
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related LeukemiaBarbara Spitzer, Kayleigh D Rutherford, Gunes Gundem, et al.
Blood|February 17, 2023
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosisAndrew J Dunbar, Dongjoo Kim, Min Lu, et al.
The New England Journal of Medicine|February 1, 2018
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaShannon L Maude, Theodore W Laetsch, Jochen Buechner, et al.
Cancer Discovery|October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase InhibitionJames J Harding, Maeve A Lowery, Alan H Shih, et al.
Cell Stem Cell|May 23, 2025
Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemiaMaria Sirenko, Soobeom Lee, Zhengxi Sun, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcomaBettina Nadorp, Audrey Lasry, Sanam Loghavi, et al.
Cancer Cell|May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformationWendy Béguelin, Relja Popovic, Matt Teater, et al.
Blood|November 22, 2019
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasmsLanzhu Yue, Vasundhara Sharma, Nathan P Horvat, et al.
Cancer Cell|July 16, 2015
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative NeoplasmsSara C Meyer, Matthew D Keller, Sophia Chiu, et al.
The New England Journal of Medicine|May 7, 2025
Enhanced CAR T-Cell Therapy for Lymphoma after Previous FailureJakub Svoboda, Daniel J Landsburg, James Gerson, et al.
Pageof 144